Cargando…
Bringing natural killer cells to the clinic
Cancer is a leading cause of mortality worldwide, with around 10 million deaths every year. Despite huge advances due to immunotherapy, the majority of cancer patients present primary or secondary resistance to these treatments. In this Found in Translation, we focus on the approaches developed to h...
Autores principales: | Chiossone, Laura, Vivier, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448638/ https://www.ncbi.nlm.nih.gov/pubmed/36066456 http://dx.doi.org/10.1084/jem.20220830 |
Ejemplares similares
-
Adoptive cell therapy: Living drugs against cancer
por: Laskowski, Tamara, et al.
Publicado: (2020) -
Drug development challenges in nontuberculous mycobacterial lung disease: TB to the rescue
por: Dartois, Véronique, et al.
Publicado: (2022) -
Escape from planned obsolescence: Hepatitis C, the cirrhotic liver, and clonal expansions
por: Branch, Andrea D.
Publicado: (2020) -
SARS-CoV-2 spike therapeutic antibodies in the age of variants
por: Baum, Alina, et al.
Publicado: (2021) -
Surmounting structural barriers to tackle endemic infectious diseases
por: Calderón, Felix, et al.
Publicado: (2021)